Identification of intravascular tumor microenvironment features predicting the recurrence of pathological stage I lung adenocarcinoma

Cancer Science

Volumn 104, Issue 9, 2013, Pages 1262-1269

  Kaseda, Kaoru ^a,b   Ishii, Genichiro ^a   Aokage, Keiju ^a   Takahashi, Akiko ^a   Kuwata, Takeshi ^a   Hishida, Tomoyuki ^a   Yoshida, Junji ^a   Kohno, Mitsutomo ^b   Nagai, Kanji ^a   Ochiai, Atsushi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V6 ANTIGEN; HERMES ANTIGEN; UVOMORULIN; VIMENTIN;

AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CANCER STAGING; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; LUNG ADENOCARCINOMA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROSCOPY; MICROVASCULATURE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR INVASION; TUMOR MICROENVIRONMENT;

ACTINS; ADENOCARCINOMA; ANTIGENS, CD34; ANTIGENS, CD44; BLOOD VESSELS; CADHERINS; ENDOTHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBROBLASTS; HUMANS; LUNG NEOPLASMS; MACROPHAGES; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT; VIMENTIN;

EID: 84883451532     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12219     Document Type: Article

References (26)

1. Kessler R, Gasser B, Massard G et al. Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. Ann Thorac Surg 1996; 62: 1489-93.
2. Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 1974; 34: 997-1004.
3. Rigau V, Molina TJ, Chaffaud C et al. Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence. Lung Cancer 2002; 38: 169-76.
4. Lee AK, DeLellis RA, Silvermann ML, Heatley GJ, Wolfe HJ. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol 1990; 8: 1457-65.
5. Ouchi K, Sugawara T, Ono H et al. Histologic features and clinical significance of venous invasion in colorectal carcinoma with hepatic metastasis. Cancer 1996; 78: 2313-7.
6. Kroeger N, Rampersaud EN, Patard JJ et al. Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. J Urol 2012; 187: 418-23.
7. Sobin LH, Wittekind C, eds. International Union Against Cancer (UICC) TNM Classification of Malignant Tumours, 6th edn. New York, NY: Wiley-Liss, 2002; 99-103.
8. Greene FL, Page DL, Fleming ID, eds. American Joint Committee on Cancer (AJCC) Cancer Staging Handbook, 6th edn. New York, NY: Springer, 2002; 191-203.
9. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-44.
10. Matsumura Y, Ishii G, Aokage K et al. Morphophenotypic characteristics of intralymphatic cancer and stromal cells susceptible to lymphogenic metastasis. Cancer Sci 2012; 103: 1342-7.
11. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
12. Yoshida J, Nagai K, Asamura H et al. Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database. J Thorac Oncol 2009; 4: 959-63.
13. Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male: female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005; 117: 294-9.
14. Asamura H, Goya T, Koshiishi Y et al. A Japanese Lung Cancer Registry study: prognosis of 13, 010 resected lung cancers. J Thorac Oncol 2008; 3: 46-52.
15. Yoshizawa A, Motoi N, Riely GJ et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma:prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011; 24: 653-64.
16. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
17. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-54.
18. Ohtaki Y, Ishii G, Nagai K et al. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma. J Thorac Oncol 2010; 5: 1507-15.
19. Kojc N, Zidar N, Vodopivec B, Gale N. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta 1 in squamous intraepithelial lesions and squamous cell carcinoma of the hypopharynx. Hum Pathol 2005; 36: 16-21.
20. Tenderenda M, Rutkowski P, Jesoniek-Kupnicka D, Kubiak R. Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index. Pathol Oncol Res 2001; 7: 129-34.
21. Korkolopoulou P, Konstantinidou AE, Kavantzas N et al. Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer. Virchows Arch 2001; 438: 603-11.
22. Duda DG, Duyverman AM, Kohno M et al. Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci USA 2010; 107: 21677-82.
23. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008; 68: 3645-54.
24. Ono K, Sugio K, Uramoto H et al. Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer-related proteins. Cancer 2009; 115: 3489-500.
25. Imai T, Horiuchi A, Shiozawa T et al. Elevated expression of E-cadherin and alpha-, beta-, and gamma-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas. Hum Pathol 2004; 35: 1469-76.
26. Ishii G, Ito TK, Aoyagi K et al. Presence of human circulating progenitor cells for cancer stromal fibroblasts in the blood of lung cancer patients. Stem Cells 2007; 25: 1469-77.